About this trial
The primary goal of the study is to test dietary intervention at glycemic control and carotenoid levels in participants with intermediate age-related macular degeneration.
Eligibility criteria
Qualifiers
Diagnosis of early to intermediate AMD with no history of retinal geographic atrophy (cRORA) or exudative disease
Eating a diet less healthy than average (Healthy Eating Index [HEI] score <61) based on 3 24-hour dietary recalls
Access to a computer or smart phone for use in the behavioral meetings (we will provide loaners for those lacking a smart phone
Because the initial questionnaires (ASA24), surveys and informed consent will be on line and in English, only individuals with fluency in English will be included. (They do not need to list English as their primary language.)
Disqualifiers
HbA1c greater than 6.5%,
Diabetes or medications used to treat diabetes or obesity (including GLP1 agonists, metformin, glyburide
Use of statins, niacin or other lipid/cholesterol modifying medications
Recent cancer (within past 3 years)
Trial design
Treatments tested in this trial
- Low glycemic Mediterranean diet behavioral modification
Treatment groups
Sponsors and collaborators
Stanford University
Lead sponsor
National Eye Institute (NEI)
Collaborator